Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight
The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.
QTRXGHIPHAABSIAAPGMEDPOABINBTXCRDLMESOIMMPIMTXCLLSCGENABVXMXCTPLRZSGMOENLVCLGNBIAFBIAFWBNTXNBPEPRXGNTAINCYADAGISPCATHEMENSMSLEEVAXNRSNPBMNRCOABIWGMABONMDONMDWPHARPPBTRADXTLSA
Read the full story at GlobeNewswire Inc. ↗IntelliStock summarizes and links to the original publisher. Data delayed 15 minutes.